In the primary analysis using staining from both antibodies for COX2 (Table 1), we found no differences in associations of the aspirin exposure variables as well as NSAIDs with breast cancer risk by COX2 protein expression status. The gene discussed is PTGS2; the disease is breast carcinoma.